1. Introduction
Enol is of great importance to synthetic chemistry since it could undergo various transformation [1,2]. As a result, new method for introducing enol moiety into organic compounds is highly desirable. To date, acyclic enol as a nucleophile was used in transition-metal catalyzed allylic substitution [3,4,5,6,7,8,9,10,11,12,13,14].
Very few cyclic enol such as 5,5-dimethylcyclohexane-1,3-dione was used in allylic substitution under Pd [15,16,17,18] and Ru [19] catalysis (eq-1 and eq-2 in Scheme 1). Interestingly, the racemic allylated 3-hydroxy-5,5-dimethylcyclohex-2-en-1-one was observed in eq-2 of Scheme 1. Iridium-catalyzed allylic substitution has become a powerful tool for the synthesis of optically active compounds [20,21]. In general, 4,4-dimethylcyclohexane-1,3-dione that is structurally unsymmetrical could carry out keto-enol isomerization to form either 3-hydroxy-6,6-dimethylcyclohex-2-en-1-one or 3-hydroxy-4,4-dimethylcyclohex-2-en-1-one [3,22] (Scheme 2); thus, stereoselective introduction of cyclic enol moiety into allyl products is a changeling task. We speculated that unsymmetrical 3-hydroxy-4,4-dimethylcyclohex-2-en-1-one may undergo enantioselective allylic substitution under Ir catalysis to form two chiral centers. In this paper, we describe Ir-catalyzed enantioselective allylic enolization of 6,6-dimethyl-3-((trimethylsilyl)oxy)cyclohex-2-en-1-one involving keto-enol isomerization.
2. Results and Discussion
We initiated with a model reaction of 6,6-dimethyl-3-((trimethylsilyl)oxy)cyclohex-2-en-1-one 1a [22], which derived from 4,4-dimethylcyclohexane-1,3-dione 1b and hexamethyldisilazane (HMDS), with (E)-cinnamyl methyl carbonate 2a in the presence of CsF and an iridacycle [23] prepared from [Ir(COD)Cl]2 and Feringa’s ligand L1 [24,25] (Figure 1). When the reaction was conducted in dichloromethane (DCM) at −20 °C, the formation of 3-hydroxy-6,6-dimethyl-2-(1-phenylallyl)cyclohex-2-en-1-one 3a was observed. Its enolated isomer, either 4,4-dimethyl-2-(1-phenylallyl)cyclohexane-1,3-dione 3a″ or 3-hydroxy-4,4-dimethyl-2-(1-phenylallyl) cyclohex-2-en-1-one 3a‴ was not found. These results suggested that it is difficult to form 3a‴ due to the repulsion between methyl and hydroxyl group. The structure of 3a was established by 2D 1H NMR and X-ray analysis of 3j (entry 1 and Figure S2; Supplementary Materials). Inspired by these results, various solvents were examined and they revealed that toluene is a proper solvent (entry 4); whereas other solvents such as DCM and acetonitrile offered 3a in poor yields with good to high ee values (entries 1, 3, and 4); THF is not favorable for this reaction (entry 2). Base plays an important role in the allylic enolization, thus, a series of bases including CsF, CsCl, Cs2CO3, CsOH, K2CO3, and 1,8-diazabicyclo [5.4.0]-7-undecene (DBU) was tested and Cs2CO3 led to the better results than the others (entries 5–8); DBU is not effective for the reaction (entry 9). The reaction was performed at a temperature ranging from −20 °C to 35 °C, and we found that the reaction at 25 °C gave superior results (entries 6, 10–13). Notably, the incomplete conversion of 1a led to a 75% yield (entry 12). Iridium salts such as [Ir(Cp*)Cl2]2 and Ir(COD)(acac) were surveyed, [Ir(Cp*)Cl2]2 was not suitable for this reaction (entry 14); Ir(COD)(acac) gave 3a in a poor yield but with high ee value (entry 15). Ligand is crucial to Ir-catalyzed asymmetric allylic substitution [20,21]. Therefore, structurally varying ligands such as L1, L2 [25], L3 [26], L4 [27], and L5 [28] (Figure 1) were explored. L1 led to a better ee value than L2; and L2 gave a higher yield than that of L1 (entry 12 vs. entry 16); L3 gave a moderate ee value; both L4 and L5 are ineffective for this reaction (entries 16–19). Moreover, either 4,4-dimethylcyclohexane-1,3-dione 1b or 2,2-dimethylcyclohexan-1-one 1c was also tested under the optimal conditions and no corresponding product was detected; these results suggested that 1a is requirable for this reaction (entry 20).
Having established the optimal reaction conditions shown in the entry 12 of Table 1, we further surveyed the scope of various allylic substrates 2. When 2a and substrates 2b–2c, 2e–2h having an electron-rich substituent (e.g., p-Et, p-iso-Propyl, p-MeO, m-Me, m-MeO, and m-EtO) on the phenyl ring were employed, the corresponding 3a–3c, 3e–3h were obtained in moderate to good yields with high regio- and enantioselectivities.
Interestingly, substrate 2d bearing a bulky tert-butyl group and 2i attaching 3,4-di-Me groups on the phenyl ring were used, 3d and 3i were also achieved in good to high yield with a high level of regio- and enantioselectivities. However, the substrates 2j–2l containing the electron-poor substituent (e.g., m-Br, m-Cl, and p-Br) on the phenyl ring were utilized, the allyl products 3j–3l were obtained in moderate to good yields with slight lowering ee values but with high regioselectivities. Naphthyl-substituted substrate 2m and heteroaryl-substituted substrates (2n and 2o) offered 3m, 3n–3o in good yield with high regio- and enantioselectivity. In particular, aliphatic-substituted substrate 2p gave 3p in a moderate yield with high regio- and enantioselectivity (Scheme 3).
The scale-up synthesis of enolated allyl product such as 3d was conducted under the optimal conditions as shown in Scheme 3. 1a (318 mg, 1.5 mmol) and the allylic substrate 2d (744 mg, 3 mmol) were employed and 3d (351 mg, 75% yield, 93% ee and 3d/3d′ = 20/1) was obtained (Scheme 4).
The application of the enolated product 3d made by this method is shown in Scheme 3. The absolute configuration of 3j was determined as S by its X-ray analysis [29] (Figure 2).
The enantioselective fluorination of 3d was realized by a treatment of 3d with N-fluorobenzenesulfonimide (NFSI, 0.15 mmol) in the presence of K2CO3 (0.25 mmol), tetrabutylammonium iodide (TBAI, 0.01 mmol) and THF/H2O (7/3) at room temperature and it gave the fluorinated 5 in an 86% yield with 99% ee and dr 3/1 (Scheme 4).
For a possible mechanism, we outline that it begins by insertion of iridium into the allyl-oxygen bond in the presence of Cs2CO3 and toluene to yield an ionized (π-allyl)-Ir-complex (Int A). The treatment of 1 with Cs2CO3 liberates 1′, the later attacks Int A to produce 3″, which leads to enolization to provide 3, regenerating the catalyst. The quaternary carbon center adjacent to the carbonyl group on the six-membered ring plays a significant role in the formation of enol 3 (or 3‴) because of the resonance effect [19] and steric effect (Scheme 5).
3. Materials and Methods
3.1. Reagents and General Methods
All manipulations were carried out under the argon atmosphere using standard Schlenk techniques. All glassware were oven or flame dried immediately prior to use. All solvents were purified and dried according to standard methods prior to use, unless stated otherwise.
1H NMR spectra were obtained at 400 MHz or 600 MHz and recorded relative to the tetramethylsilane signal (0 ppm) or residual protio-solvent (7.26 ppm for CDCl3). 13C NMR spectra were obtained at 100 MHz or 150 MHz, and chemical shifts were recorded relative to the solvent resonance (CDCl3, 77.16 ppm). 19F NMR spectra were obtained at 376 MHz or 565 MHz. Data for NMR are recorded as follows: chemical shift (δ, ppm), multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet or unresolved, br = broad singlet, coupling constant(s) in Hz, integration).
The phosphoramidite ligands [24,27,30], substituted allylic carbonates [31], were prepared according to the known procedures. Other chemicals were purchased from commercial suppliers and used without further purification, unless mentioned.
3.2. Synthetic Procedures
General Procedure for the Synthesis of 3: [Ir(COD)Cl]2 (0.004 mmol, 4 mol%), phosphoramidite ligand L1 (0.008 mmol, 8 mol%) were dissolved in THF (0.5 mL) and n-propylamine (0.3 mL) in a dry Schlenk tube filled with argon. The reaction mixture was heated at 50 °C for 30 min and then the volatile solvents were removed under vacuum to give a yellow solid. After that, allylic carbonate 2 (0.20 mmol), cesium carbonate (Cs2CO3, 0.12 mmol), and toluene (1.0 mL) were added. In another dry Schlenk tube, 6,6-dimethyl-3-((trimethylsilyl) oxy) cyclohex-2-en-1-one 1a was prepared from 4,4-dimethylcyclohexane-1,3-cyclohexanedione (0.10 mmol) and hexamethyldisilazane (HMDS) (0.15 mmol) in DCM (2.0 mL), under stirring for 2.5 h at room temperature, and the solvent was removed under vacuum to give a light-yellow liquid which was transferred through a syringe into the above mentioned Schlenk tube. The reaction was stirred at room temperature for 12 h. Then the mixture was washed with brine. After the organic phase was collected, the aqueous phase was extracted with DCM. The combined organic phase was dried over anhydrous Na2SO4 and concentrated on a rotary evaporator. The crude residue was purified by flash column chromatography (petroleum ether/ethyl acetate) to give the desired products 3.
(S)-3-Hydroxy-6,6-dimethyl-2-(1-phenylallyl)cyclohex-2-en-1-one (3a), white solid; m.p.: 103–105 °C; 75% yield (19.2 mg); HPLC ee: 91% [Daicel CHIRALPAK AD-H (0.46 cm × 25 cm); n-hexane/2-propanol = 90/10; flow rate = 1.0 mL/min; detection wavelength = 254 nm; tR = 6.77 (minor), 8.22 (major) min]. [α]D20 = +22.3 (c 1.0, CHCl3). 1H NMR (600 MHz, CD3CN) δ 7.28–7.24 (m, 2H), 7.21 (d, J = 7.8 Hz, 2H), 7.17–7.13 (m, 1H), 6.49–6.43 (m, 1H), 5.11–5.05 (m, 2H), 4.88 (d, J = 7.8 Hz, 1H), 2.57–2.54 (m, 2H), 1.82 (t, J = 6.0 Hz, 2H), 1.06 (d, J = 6.0 Hz, 6H).13C NMR (150 MHz, CD3CN) δ 212.6, 172.2, 144.4, 140.2, 128.5, 127.9, 126.1, 115.9, 115.4, 44.2, 39.8, 34.7, 27.7, 24.8, 24.8. IR (KBr): νmax (cm−1) = 3648, 3523, 3442, 1715, 1627, 1400, 1275, 1260, 764, 749. HRMS (ESI+) calcd for C17H20NaO2 [M+Na]+: 279.1356, Found: 279.1362.
(S)-3-Hydroxy-2-(1-(4-isopropylphenyl)allyl)-6,6-dimethyl-cyclohex-2-en-1-one (3c), pale yellow solid; m.p.: 99–101 °C; 78% yield (23.2 mg); HPLC ee: 90% [Daicel CHIRALPAK AD-H (0.46 cm × 25 cm); n-hexane/2-propanol = 90/10; flow rate = 1.0 mL/min; detection wavelength = 254 nm; tR = 6.56 (minor), 7.41 (major) min]. [α]D20 = −5.5 (c 1.0, CHCl3). 1H NMR (600 MHz, DMSO-d6) δ 10.45 (s, 1H), 7.10–7.00 (m, 4H), 6.44–6.38 (m, 1H), 5.02–4.93 (m, 2H), 4.76 (d, J = 9.0 Hz, 1H), 2.52–2.50 (m, 3H), 1.73 (t, J = 6.6 Hz, 2H), 1.17 (d, J = 7.2 Hz, 6H), 0.99 (d, J = 3.6 Hz, 6H). 13C NMR (150 MHz, DMSO-d6) δ 201.1, 170.6, 145.4, 141.5, 140.5, 127.3, 126.0, 115.0, 114.9, 43.5, 34.2, 33.4, 26.9, 25.3, 25.2, 24.5, 24.4. IR (KBr): νmax (cm−1) = 3498, 3431, 3011, 1676, 1632, 1413, 1265, 1243, 743. HRMS (ESI+) calcd for C20H26NaO2 [M + Na]+: 321.1825, Found: 321.1823.
(S)-3-Hydroxy-2-(1-(4-methoxyphenyl)allyl)-6,6-dimethyl-cyclohex-2-en-1-one (3e), yellow solid; m.p.: 75–77 °C; 70% yield (20.1 mg); HPLC ee: 83% [Daicel CHIRALPAK AD-H (0.46 cm × 25 cm); n-hexane/2-propanol = 90/10; flow rate = 1.0 mL/min; detection wavelength = 254 nm; tR = 10.52 (minor), 12.24 (major) min]. [α]D20 = +6.8 (c 1.0, CHCl3). 1H NMR (600 MHz, CD3CN) δ 7.01 (d, J = 9.0 Hz, 2H), 6.71 (d, J = 9.0 Hz, 2H), 6.36–6.30 (m, 1H), 5.00–4.89 (m, 2H), 4.71 (d, J = 7.8 Hz, 1H), 3.65 (s, 3H), 2.45–2.42 (m, 2H), 1.70 (t, J = 6.0 Hz, 2H), 0.95 (d, J = 4.2 Hz, 6H). 13C NMR (150 MHz, CD3CN) δ 202.2, 176.0, 158.2, 140.6, 135.9, 128.8, 116.0, 115.0, 113.7, 55.3, 43.3, 39.7, 34.5, 27.6, 24.7, 24.7. IR (KBr): νmax (cm−1) = 3523, 3129, 3006, 2990, 1607, 1509, 1400, 1275, 1260, 764, 749. HRMS (ESI+) calcd for C18H22NaO3 [M + Na] +: 309.1461, Found: 309.1462.
(S)-2-(1-(3-Ethoxyphenyl)allyl)-3-hydroxy-6,6-dimethyl-cyclohex-2-en-1-one (3h), yellow solid; m.p.: 83–85 °C; 76% yield (22.8 mg); HPLC ee: 89% [Daicel CHIRALPAK AD-H (0.46 cm × 25 cm); n-hexane/2-propanol = 90/10; flow rate = 1.0 mL/min; detection wavelength = 254 nm; tR = 8.08 (major), 8.64 (minor) min]. [α]D20 = −21.5 (c 1.0, CHCl3). 1H NMR (600 MHz, DMSO-d6) δ 10.45 (s, 1H), 7.12–7.07 (m, 1H), 6.68 (d, J = 7.8 Hz, 1H), 6.65–6.63 (m, 2H), 6.42–6.36 (m, 1H), 5.00–4.97 (m, 2H), 4.75 (d, J = 9.0 Hz, 1H), 3.93 (dd, J = 6.6, 2.4 Hz, 2H), 2.50–2.49 (m, 2H), 1.72 (t, J = 6.6 Hz, 2H), 1.29 (t, J = 6.6 Hz, 3H), 0.99 (d, J = 3.6 Hz, 6H). 13C NMR (150 MHz, DMSO-d6) δ 201.0, 172.3, 159.7, 146.3, 140.5, 129.7, 120.4, 116.1, 115.6, 114.4, 112.1, 63.9, 44.4, 40.0, 34.8, 27.8, 25.1, 15.1. IR (KBr): νmax (cm−1) = 3498, 3465, 3009, 1665, 1620, 1342, 1298, 1213, 734. HRMS (ESI+) calcd for C19H24NaO3 [M + Na]+: 323.1618, Found: 323.1617.
4. Conclusions
In conclusion, we developed Ir-catalyzed allylic enolization of 6,6-dimethyl-3-((trimethylsilyl)oxy)cyclohex-2-en-1-one involving keto-enol isomerization, which afforded the enolated allyl products in good to high yields with high regio- and enantioselectivities. This method allows the use of 6,6-dimethyl-3-((trimethylsilyl)oxy)cyclohex-2-en-1-one, tolerates numerous functionalized groups, and provides a new way for the construction of a chiral carbon-fluorine center.
Conceptualization, X.-M.Z.; methodology, X.-L.W. and J.-T.C.; validation, X.-L.W. and J.-T.C.; investigation, X.-L.W.; resources, X.-M.Z. and S.-C.Z.; writing—original draft preparation, X.-L.W.; writing—review and editing, X.-M.Z. and S.-C.Z.; supervision, X.-M.Z. and S.-C.Z. All authors have read and agreed to the published version of the manuscript.
Not applicable.
Not applicable.
Not applicable.
The authors are grateful to the Chinese National Science Foundation (NSF) (grant number 21971193).
The authors declare no conflict of interest.
Not applicable.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Scheme 1. Cyclohexane-1,3-dione derivatives employed in allylic substitution under Pd, Ru, and Ir catalysis.
Scheme 3. Scope of the allylic substrates 2. Reaction conditions: [Ir(COD)Cl]2 (0.004 mmol), L1 (0.008 mmol), 1a (0.1 mmol), 2 (0.2 mmol), Cs2CO3 (0.12 mmol), and PhMe (1 mL). Yield referred to isolated yield and ee was determined by a chiral HPLC.
Scheme 4. Scale-up synthesis of 3d and its fluorination for the synthesis of 5 with a chiral C-F center.
Screening reaction conditions for Ir-catalyzed reaction between 6,6-dimethyl-3-((trimethylsilyl)oxy)cyclohex-2-en-1-one 1a and allylic substrate 2a a.
[Image omitted. Please see PDF.] | ||||||||
Entry | Ir catalyst | Ligand | Base | Solvent | Temp (°C) | 3a/3a′b | Yield b (%) | ee c (%) |
1 | [Ir(COD)Cl]2 | L1 | CsF | DCM | −20 | >20/1 | 13 | 85 |
2 | [Ir(COD)Cl]2 | L1 | CsF | THF | −20 | - | - | - |
3 | [Ir(COD)Cl]2 | L1 | CsF | CH3CN | −20 | >20/1 | 18 | 73 |
4 | [Ir(COD)Cl]2 | L1 | CsF | Toluene | −20 | >20/1 | 21 | 91 |
5 | [Ir(COD)Cl]2 | L1 | CsCl | Toluene | −20 | >20/1 | 19 | 70 |
6 | [Ir(COD)Cl]2 | L1 | Cs2CO3 | Toluene | −20 | >20/1 | 27 | 91 |
7 | [Ir(COD)Cl]2 | L1 | CsOH | Toluene | −20 | >20/1 | 49 | 71 |
8 | [Ir(COD)Cl]2 | L1 | K2CO3 | Toluene | −20 | >20/1 | 31 | 80 |
9 | [Ir(COD)Cl]2 | L1 | DBU | Toluene | −20 | - | nr | - |
10 | [Ir(COD)Cl]2 | L1 | Cs2CO3 | Toluene | 0 | >20/1 | 52 | 87 |
11 | [Ir(COD)Cl]2 | L1 | Cs2CO3 | Toluene | 10 | >20/1 | 60 | 92 |
12 | [Ir(COD)Cl]2 | L1 | Cs2CO3 | Toluene | 25 | >20/1 | 75 | 91 |
13 | [Ir(COD)Cl]2 | L1 | Cs2CO3 | Toluene | 35 | >20/1 | 86 | 85 |
14 | [Ir(Cp*)Cl2]2 | L1 | Cs2CO3 | Toluene | 25 | - | nr | - |
15 | Ir(COD)(acac) | L1 | Cs2CO3 | Toluene | 25 | >20/1 | 19 | 93 |
16 | [Ir(COD)Cl]2 | L2 | Cs2CO3 | Toluene | 25 | >20/1 | 78 | 87 |
17 | [Ir(COD)Cl]2 | L3 | Cs2CO3 | Toluene | 25 | >20/1 | 30 | 78 |
18 | [Ir(COD)Cl]2 | L4 | Cs2CO3 | Toluene | 25 | - | - | - |
19 | [Ir(COD)Cl]2 | L5 | Cs2CO3 | Toluene | 25 | - | - | - |
20 d | [Ir(COD)Cl]2 | L1 | Cs2CO3 | Toluene | 25 | - | nr | - |
a Reaction conditions: Ir salt (0.004 mmol), ligand (0.008 mmol), 1a (0.10 mmol), 2a (0.20 mmol), base (0.12 mmol), and solvent (1 mL). b Isolated yield. c Determined by a chiral HPLC. d Either 1b or 1c instead of 1a was used.
Supplementary Materials
The following supporting information can be downloaded at:
References
1. Kresge, A.J. Ingold Lecture. Reactive Intermediates: Carboxylic Acid Enols and Other Unstable Species. Chem. Soc. Rev.; 1996; 25, 275. [DOI: https://dx.doi.org/10.1039/cs9962500275]
2. Chiang, Y.; Kresge, A.J.; Santaballa, J.A.; Wirz, J. Ketonization of Acetophenone Enol in Aqueous Buffer Solutions. Rate-Equilibrium Relations and Mechanism of the Uncatalyzed Reaction. J. Am. Chem. Soc.; 1988; 110, pp. 5506-5510. [DOI: https://dx.doi.org/10.1021/ja00224a039]
3. Wright, T.B.; Evans, P.A. Catalytic Enantioselective Alkylation of Prochiral Enolates. Chem. Rev.; 2021; 121, pp. 9196-9242. [DOI: https://dx.doi.org/10.1021/acs.chemrev.0c00564]
4. Genet, J.P.; Ferroud, D.; Juge, S.; Montes, J.R. Synthesis of α-Amino Acids. Schiff Base of Glycine Methyl Ester. A New and Efficient Prochiral Nucleophile in Palladium Chiral Catalytic Allylation. Tetrahedron Lett.; 1986; 27, pp. 4573-4576. [DOI: https://dx.doi.org/10.1016/S0040-4039(00)85006-6]
5. Giambastiani, G.; Poli, G. Palladium Catalyzed Alkylation with Allylic Acetates under Neutral Conditions. J. Org. Chem.; 1998; 63, pp. 9608-9609. [DOI: https://dx.doi.org/10.1021/jo981599c]
6. Trost, B.M.; Schroeder, G.M. Palladium-Catalyzed Asymmetric Alkylation of Ketone Enolates. J. Am. Chem. Soc.; 1999; 121, pp. 6759-6760. [DOI: https://dx.doi.org/10.1021/ja991135b]
7. Graening, T.; Hartwig, J.F. Iridium-Catalyzed Regio- and Enantioselective Allylation of Ketone Enolates. J. Am. Chem. Soc.; 2005; 127, pp. 17192-17193. [DOI: https://dx.doi.org/10.1021/ja0566275]
8. Weix, D.J.; Hartwig, J.F. Regioselective and Enantioselective Iridium-Catalyzed Allylation of Enamines. J. Am. Chem. Soc.; 2007; 129, pp. 7720-7721. [DOI: https://dx.doi.org/10.1021/ja071455s]
9. Chen, M.; Hartwig, J.F. Iridium-Catalyzed Enantioselective Allylic Substitution of Unstabilized Enolates Derived from α,β-Unsaturated Ketones. Angew. Chem. Int. Ed.; 2014; 53, pp. 8691-8695. [DOI: https://dx.doi.org/10.1002/anie.201403844]
10. Chen, M.; Hartwig, J.F. Iridium-Catalyzed Enantioselective Allylic Substitution of Enol Silanes from Vinylogous Esters and Amides. J. Am. Chem. Soc.; 2015; 137, pp. 13972-13979. [DOI: https://dx.doi.org/10.1021/jacs.5b09980]
11. Jiang, X.; Chen, W.; Hartwig, J.F. Iridium-Catalyzed Diastereoselective and Enantioselective Allylic Substitutions with Acyclic α-Alkoxy Ketones. Angew. Chem. Int. Ed.; 2016; 55, pp. 5819-5823. [DOI: https://dx.doi.org/10.1002/anie.201600235] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27038004]
12. Hartwig, J.F.; Stanley, L.M. Mechanistically Driven Development of Iridium Catalysts for Asymmetric Allylic Substitution. Acc. Chem. Res.; 2010; 43, pp. 1461-1475. [DOI: https://dx.doi.org/10.1021/ar100047x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20873839]
13. Liu, W.-B.; Reeves, C.M.; Stoltz, B.M. Enantio-, Diastereo-, and Regioselective Iridium-Catalyzed Asymmetric Allylic Alkylation of Acyclic β-Ketoesters. J. Am. Chem. Soc.; 2013; 135, pp. 17298-17301. [DOI: https://dx.doi.org/10.1021/ja4097829]
14. Liang, X.; Wei, K.; Yang, Y.-R. Iridium-Catalyzed Enantioselective Allylation of Silyl Enol Ethers Derived from Ketones and α,β-Unsaturated Ketones. Chem. Commun.; 2015; 51, pp. 17471-17474. [DOI: https://dx.doi.org/10.1039/C5CC07221B] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26477399]
15. Sigismondi, S.; Sinou, D. Palladium(0)-Catalyzed Substitution of Allylic Substrates in an Aqueous-Organic Medium. Influence of Various Parameters on the Selectivity of the Reaction. J. Mol. Catal. A Chem.; 1997; 116, pp. 289-296. [DOI: https://dx.doi.org/10.1016/S1381-1169(96)00145-8]
16. Kayaki, Y.; Koda, T.; Ikariya, T. Halide-Free Dehydrative Allylation Using Allylic Alcohols Promoted by a Palladium−Triphenyl Phosphite Catalyst. J. Org. Chem.; 2004; 69, pp. 2595-2597. [DOI: https://dx.doi.org/10.1021/jo030370g] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15049667]
17. Kinoshita, H.; Shinokubo, H.; Oshima, K. Water Enables Direct Use of Allyl Alcohol for Tsuji−Trost Reaction without Activators. Org. Lett.; 2004; 6, pp. 4085-4088. [DOI: https://dx.doi.org/10.1021/ol048207a] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15496105]
18. Gan, K.-H.; Jhong, C.-J.; Yang, S.-C. Direct Palladium/Carboxylic Acid-Catalyzed C-Allylation of Cyclic 1,3-Diones with Allylic Alcohols in Water. Tetrahedron; 2008; 64, pp. 1204-1212. [DOI: https://dx.doi.org/10.1016/j.tet.2007.11.082]
19. Gruber, S.; Pregosin, P. Ruthenium Catalyzed Selective Regio-and-Mono-Allylation of Cyclic 1,3-Diketones Using Allyl Alcohols as Substrates. Adv. Synth. Catal.; 2009; 351, pp. 3235-3242. [DOI: https://dx.doi.org/10.1002/adsc.200900568]
20. Cheng, Q.; Tu, H.-F.; Zheng, C.; Qu, J.-P.; Helmchen, G.; You, S.-L. Iridium-Catalyzed Asymmetric Allylic Substitution Reactions. Chem. Rev.; 2019; 119, pp. 1855-1969. [DOI: https://dx.doi.org/10.1021/acs.chemrev.8b00506]
21. Qu, J.; Helmchen, G. Applications of Iridium-Catalyzed Asymmetric Allylic Substitution Reactions in Target-Oriented Synthesis. Acc. Chem. Res.; 2017; 50, pp. 2539-2555. [DOI: https://dx.doi.org/10.1021/acs.accounts.7b00300]
22. Chu, D.T.W.; Huckin, S.N. Cshemistry of Hexamethyldisilazane. Silylation of β-Diketones and Amination of β-Triketones. Can. J. Chem.; 1980; 58, pp. 138-142. [DOI: https://dx.doi.org/10.1139/v80-022]
23. Kiener, C.A.; Shu, C.; Incarvito, C.; Hartwig, J.F. Identification of an Activated Catalyst in the Iridium-Catalyzed Allylic Amination and Etherification. Increased Rates, Scope, and Selectivity. J. Am. Chem. Soc.; 2003; 125, pp. 14272-14273. [DOI: https://dx.doi.org/10.1021/ja038319h]
24. Tissot-Croset, K.; Polet, D.; Gille, S.; Hawner, C.; Alexakis, A. Synthesis and Use of a Phosphoramidite Ligand for the Copper-Catalyzed Enantioselective Allylic Substitution. Tandem Allylic Substitution/Ring-Closing Metathesis. Synthesis; 2004; 2004, pp. 2586-2590. [DOI: https://dx.doi.org/10.1055/s-2004-829188]
25. Arnold, L.A.; Imbos, R.; Mandoli, A.; de Vries, A.H.M.; Naasz, R.; Feringa, B.L. Enantioselective Catalytic Conjugate Addition of Dialkylzinc Reagents Using Copper–Phosphoramidite Complexes; Ligand Variation and Non-Linear Effects. Tetrahedron; 2000; 56, pp. 2865-2878. [DOI: https://dx.doi.org/10.1016/S0040-4020(00)00142-3]
26. Hoen, R.; van den Berg, M.; Bernsmann, H.; Minnaard, A.J.; de Vries, J.G.; Feringa, B.L. Catechol-Based Phosphoramidites: A New Class of Chiral Ligands for Rhodium-Catalyzed Asymmetric Hydrogenations. Org. Lett.; 2004; 6, pp. 1433-1436. [DOI: https://dx.doi.org/10.1021/ol049726g]
27. Alexakis, A.; Rosset, S.; Allamand, J.; March, S.; Guillen, F.; Benhaim, C. Novel Biphenol Phosphoramidite Ligands for the Enantioselective Copper-Catalyzed Conjugate Addition of Dialkyl Zincs. Synlett; 2001; 2001, pp. 1375-1378. [DOI: https://dx.doi.org/10.1055/s-2001-16791]
28. Shintani, R.; Park, S.; Duan, W.-L.; Hayashi, T. Palladium-Catalyzed Asymmetric [3+3] Cycloaddition of Trimethylenemethane Derivatives with Nitrones. Angew. Chem. Int. Ed.; 2007; 46, pp. 5901-5903. [DOI: https://dx.doi.org/10.1002/anie.200701529]
29. The Cambridge Crystallographic Data Centre. CCDC 2098319. Available online: https://www.ccdc.cam.ac.uk/ (accessed on 7 September 2022).
30. Naasz, R.; Arnold, L.A.; Minnaard, A.J.; Feringa, B.L. Highly Enantioselective Copper-Phosphoramidite Catalyzed Kinetic Resolution of Chiral 2-Cyclohexenones. Angew. Chem. Int. Ed.; 2001; 40, pp. 927-930. [DOI: https://dx.doi.org/10.1002/1521-3773(20010302)40:5<927::AID-ANIE927>3.0.CO;2-K]
31. Wuts, P.G.M.; Ashford, S.W.; Anderson, A.M.; Atkins, J.R. New Process for the Preparation of Methyl Carbonates. Org. Lett.; 2003; 5, pp. 1483-1485. [DOI: https://dx.doi.org/10.1021/ol034274d]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
The utilization of 6,6-dimethyl-3-((trimethylsilyl)oxy)cyclohex-2-en-1-one made from an unsymmetrical 4,4-dimethylcyclohexane-1,3-dione in iridium-catalyzed allylic enolization involving keto-enol isomerization is accomplished under mild conditions. The chemoselectivity, regioselectivity, and enantioselectivity are facilitated by the quaternary carbon and adjusting the reaction conditions. This method provides the substituted 2-(but-3-en-2-yl)-3-hydroxy-6,6-dimethylcyclohex-2-en-1-ones in good to high yields with high level of chemo-, regio-, and enantioselectivities. The chiral carbon-fluorine bond formation is induced by an adjacent chiral carbon center of the allylated 3-hydroxy-6,6-dimethylcyclohex-2-en-1-one, as well.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer